EU Panel Backs Lilly Weight-Loss Drug Orforglipron

The EU Committee for Medicinal Products for Human Use gave a positive opinion on Eli Lilly's oral weight-loss drug Orforglipron, also called Foundayo. Divi's Laboratories shares were in focus, according to the report.